Platinum
Gold
Silver
Bronze
Confirmed Sponsors
The European Society of Cataract and Refractive Surgeons
Confirmed Sponsors
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care.
Being a truly global company, we work in 60 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson and is composed of two divisions, Johnson & Johnson Surgical Vision and Johnson & Johnson Vision Care (Contact Lens).
Services include Intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastic, Microkeratomes and related products used in cataract and refractive surgery.
Johnson and Johnson Surgical Vision is based in Santa Ana, California, and Johnson & Johnson Vision Care is based in Jacksonville, Florida. JJV employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.
In February 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson.
Allergan, an AbbVie company, has dedicated 75 years to advancing eye care, launching 125+ products for prevalent eye conditions. We continue our commitment to helping ECPs deliver superior patient care through R&D, outreach programs, and educational support.
Heidelberg Engineering continuously optimises imaging and healthcare data technologies to provide ophthalmic solutions that empower researchers, clinicians, and surgeons to improve patient care. From its inception in 1990, the company has taken a collaborative approach to development of innovative products that deliver clinically relevant benefits.
Uncompromising quality and education play a large part in fostering confident treatment decisions that have become synonymous with the global brand. The company’s substantial expertise in the development and implementation of intelligent image and data management solutions complements its distinguished history in the design, manufacture, and distribution of ophthalmic instruments.
Heidelberg Engineering’s growing product portfolio combines these core technologies: confocal and digital microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR) and large-scale data analysis.
Most recently Heidelberg Engineering has acquired novel OCT technology to facilitate remote monitoring and have introduced a fully digital microscope, leveraging Heidelberg image quality into the surgical imaging space.
STAAR Surgical designs, develops, manufactures, markets and implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. More than 2 million lenses have been distributed worldwide.
| VSY Biotechnology Gmbh is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology and orthopedics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe.
Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems , viscoelastics for ophthalmology and orthopedics and hyaluronic acid (HA) viscosupplement products for orthopedics. Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 80 countries around the globe from our headquarters with a professional marketing and distribution approach. With our know-how in biotechnology, we will continue to enlighten the world by combining these disciplines for the patients. The company is owned by Evmann Investments Holding BV at 100%. Evmann Investments Holding BV is a Dutch resident Holding company which currently has investments in ophthalmology and orthopedics industries. Its strategy is to make investments especially in areas creating value for a healthier life under its motto of “Invest for Life”. |
Driving progress, efficiency and healthcare access. With a special focus on ophthalmology, ophthalmic surgery and visualization systems in the field of microsurgery, ZEISS Medical Technology supports healthcare professionals in setting new standards of care with proven medical technology and broad application competence based on cutting-edge innovations.
Aurion Biotech is a clinical-stage biotech company, whose mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech received the prestigious Prix Galien award for best start-up in biotech.
The Company’s first candidate is for the treatment of corneal edema secondary to corneal endothelial disease, and is the first off-the-shelf, clinically validated cell therapy for corneal care, having received regulatory approval in Japan.
Aurion Biotech is preparing for clinical trials in the U.S. Privately held, Aurion Biotech is backed by leading investors that include Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision / KKR, and Visionary Ventures.
To learn more about Aurion Biotech, visit www.aurionbiotech.com
Bausch + Lomb is a leading global eye care company celebrating 170 years of experience in ophthalmology. Our Surgical Division provides a comprehensive portfolio for anterior, posterior, premium and glaucoma surgery.
The new SeeLuma™ Fully Digital Surgical Visualization Platform is our latest innovation. We also now offer the Minimally Invasive Micro Sclerostomy (MIMS®) surgical procedure for the treatment of glaucoma.
The Stellaris Elite™ vision enhancement system, the LuxSmart™, IC-8® and enVista® premium IOLs, plus the Technolas® TENEO™ 317 M2 Excimer Laser also feature in our range.
Visit us on booth B203 to learn more. bauschsurgical.eu
Rayner is leading the way in ophthalmic innovation with IOLs and ophthalmic solutions designed to provide surgeons and patients with the best visual outcomes. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.
With more than 70 years of continuous growth and experience, we now sell to over 80 countries. Our mission is to deliver innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in us to improve sight and quality of life.
Rayner has a broad portfolio of products across the patient pathway, including monofocal and premium Intraocular Lenses (IOLs), a full range of Ophthalmic Viscosurgical Devices (OVDs), a family of Ocular Surface Disease (OSD) solutions and RayPRO, our patient outcomes digital platform.
Rayner is a British company and the only manufacturer of intraocular lenses in the UK.
SCHWIND eye-tech-solutions stands as a pioneer in the refractive market, driving advanced solutions for vision correction procedures and building strong relationships with customers.
The SCHWIND AMARIS excimer and SCHWIND ATOS femtosecond laser systems cover an outstanding broad range of applications, from PRK, TransPRK (i.e. SmartSurfACE), LASEK, FemtoLASIK, PTK, TransPTK, CXL, and keratoplasty with the AMARIS product family to LASIK flap and lenticule extraction (i.e. SmartSight) with the ATOS. Another key differentiator is, that SCHWIND diagnostic devices are seamlessly integrated in the laser environment.
BVI® is refocusing the future of vision.
As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries.
We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye. Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept – taking pride in delivering innovative solutions for our physicians and patients, based on their needs.
We trust and empower our associates to make decisions and solve problems because collaboration drives us. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.
Driven by insatiable curiosity, the love of science and passion for vision, Cassini has been dedicated to pushing the boundaries on personalized, thorough and accurate ophthalmic solutions for well over a decade.
Independently, and in collaboration with our vision-care partners, we strive to make the gift of lifelong sight accessible and possible the world over.
As innovative and progressive thought-leaders, we empower surgeons with the efficient, user-friendly tools, collaboration and support they need to make confident decisions for optimal outcomes.
iSTAR Medical pioneers minimally invasive, ophthalmic implants for safe, meaningful and sustained treatment of glaucoma patients. MINIject® is the only commercially available supraciliary MIGS device and is made from STAR® material, which is soft and flexible, medical-grade, micro-porous silicone enabling bio-integration of surrounding tissues. Clinical trials show that IOP is reduced by 39% to a mean of 14.4mmHg at two years post-surgery. MINIject received CE marking in late 2021 and the US FDA trial (STAR-V) for MINIject is in progress.
A new name in the ophthalmic industry, yet a team that embodies ophthalmology in Europe, we are Medevise Consulting. It starts with a Board of Directors led by Kristine Morrill and Paul Bikard and extends through to the management team and service leaders. Medevise Consulting represents a new approach that marries passion, experience and diligence to every project.
Our Vision: To be the partner of choice for medical device innovators in ophthalmology.
Our Mission: To put the best medical device innovation into the hands of ophthalmologists across Europe to improve patient experience and outcomes.
Our Values: We believe in working together with our clients to achieve excellence. We strive for impeccable execution – taking pride in our quality management approach. We apply creative thinking to everything to ensure we develop unique and effective solutions to all client challenges, large or small. We build client relationships for the long-haul.